• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angina after incomplete revascularization: therapeutic solutions.

作者信息

Natale Enrico, Denitza Tinti Maria

机构信息

UOC Cardiologia 1, Ospedale San Camillo, Roma.

出版信息

Eur Heart J Suppl. 2019 Mar;21(Suppl B):B57-B58. doi: 10.1093/eurheartj/suz010. Epub 2019 Mar 29.

DOI:10.1093/eurheartj/suz010
PMID:30948950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6439909/
Abstract
摘要

相似文献

1
Angina after incomplete revascularization: therapeutic solutions.不完全血运重建后心绞痛：治疗方案
Eur Heart J Suppl. 2019 Mar;21(Suppl B):B57-B58. doi: 10.1093/eurheartj/suz010. Epub 2019 Mar 29.
2
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.雷诺嗪对经皮冠状动脉介入治疗后不完全血运重建心绞痛和生活质量的影响：来自雷诺嗪治疗不完全血管重建（RIVER-PCI）试验的结果。
Circulation. 2016 Jan 5;133(1):39-47. doi: 10.1161/CIRCULATIONAHA.115.019768. Epub 2015 Nov 10.
3
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.在经皮冠状动脉介入治疗后不完全血运重建患者中使用雷诺嗪：雷诺嗪用于经皮冠状动脉介入治疗后不完全血管重建（RIVER-PCI）试验的设计和原理。
Am Heart J. 2013 Dec;166(6):953-959.e3. doi: 10.1016/j.ahj.2013.08.004. Epub 2013 Oct 16.
4
Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.异搏定和雷诺嗪对微血管性心绞痛患者的影响。
Am J Cardiol. 2013 Jul 1;112(1):8-13. doi: 10.1016/j.amjcard.2013.02.045. Epub 2013 Apr 1.
5
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.经皮冠状动脉介入治疗（PCI）后不完全血运重建患者应用雷诺嗪（RIVER-PCI）：一项多中心、随机、双盲、安慰剂对照试验。
Lancet. 2016 Jan 9;387(10014):136-45. doi: 10.1016/S0140-6736(15)00459-6. Epub 2015 Oct 22.
6
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.伊伐布雷定对有冠状动脉血运重建史患者的抗心绞痛疗效。
Angiology. 2017 Jan;68(1):10-18. doi: 10.1177/0003319716630499. Epub 2016 Mar 8.
7
Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.慢性稳定性心绞痛的药物治疗：聚焦于雷诺嗪
Cardiovasc Drugs Ther. 2016 Aug;30(4):393-398. doi: 10.1007/s10557-016-6674-1.
8
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.经皮冠状动脉介入治疗和冠状动脉旁路移植术后不完全血运重建的发生率、预测因素和结局：SYNTAX 数据 3 年亚组分析。
Eur J Cardiothorac Surg. 2012 Mar;41(3):535-41. doi: 10.1093/ejcts/ezr105. Epub 2011 Dec 21.
9
Angina and Its Management.心绞痛及其治疗
J Cardiovasc Pharmacol Ther. 2017 May;22(3):199-209. doi: 10.1177/1074248416679733. Epub 2016 Dec 14.
10
Incomplete revascularization reduces survival benefit of coronary artery bypass grafting: role of off-pump surgery.不完全血运重建降低冠状动脉旁路移植术的生存获益：非体外循环手术的作用。
J Thorac Cardiovasc Surg. 2008 Jul;136(1):29-36. doi: 10.1016/j.jtcvs.2007.07.059.

本文引用的文献

1
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.2013年欧洲心脏病学会稳定型冠状动脉疾病管理指南：欧洲心脏病学会稳定型冠状动脉疾病管理特别工作组
Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30.
2
The adequacy of myocardial revascularization in patients with multivessel coronary artery disease.多支冠状动脉疾病患者的心肌血运重建是否充分。
Int J Cardiol. 2013 Oct 3;168(3):1748-57. doi: 10.1016/j.ijcard.2013.05.004. Epub 2013 Jun 3.
3
Multivessel disease: from reasonably incomplete to functionally complete revascularization.多支血管病变：从适度不完全血运重建到功能完全血运重建。
Circulation. 2012 May 29;125(21):2557-9. doi: 10.1161/CIRCULATIONAHA.112.106872. Epub 2012 May 1.
4
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.采用或不采用经皮冠状动脉介入治疗的优化药物治疗以减轻缺血负担：来自利用血运重建和强化药物评估的临床结果（COURAGE）试验核子亚研究的结果
Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.
5
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.RITA-2试验的七年结果：冠状动脉血管成形术与药物治疗对比
J Am Coll Cardiol. 2003 Oct 1;42(7):1161-70. doi: 10.1016/s0735-1097(03)00951-3.
6
Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry.血管重建完整性对接受冠状动脉搭桥手术的三支血管病变患者长期预后的影响。冠状动脉手术研究（CASS）注册报告。
Circulation. 1992 Aug;86(2):446-57. doi: 10.1161/01.cir.86.2.446.